AdobeStock_292279272

NICE guideline

COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response

2020-08-25T13:28:00+01:00By

The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic.

Educational resources

Webinar banner 3x22

Non-alcoholic steatohepatitis: identification, management, and referral pathways

Commissioned by Intercept Pharma UK and Ireland Ltd

The content on this page is intended for UK healthcare professionals only.